About Immatics N.V
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
Leadership at Immatics N.V
The team at the top of the org chart.
Harpreet Singh
CEO
286 reports
Cedrik Britten
Chief Medical Officer
128 reports
Steffen Walter
Chief Operating Officer
63 reports
Carsten Reinhardt
Managing Director & Chief Development Officer
32 reports
Amie Krause
Chief People Officer
18 reports
Rainer Kramer
Managing Director & Chief Business Officer
17 reports
Venkat Ramanan
Chief Financial Officer
9 reports
Edward Sturchio
General Counsel and Corporate Secretary
8 reports
Toni Weinschenk
Chief Innovation Officer
2 reports
Board
Anne Kerber
Scientific Advisory Board Member
Peter Chambré
Chairman
Hans-Georg Rammensee
Chairman of Scientific Advisory Board
Patrick Hwu
Scientific Advisory Board Member
Cassian Yee
Scientific Advisory Board Member
Roland Kontermann
Scientific Advisory Board